Trial intelligence / Profile preview

Vorapaxar Pharmacodynamics with Prasugrel or Ticagrelor in Post-MI Patients

NCT02545933Phase 4Completed

Sponsor
University of Florida
Start
Feb 2016
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vorapaxar in myocardial infarction (MI), sponsored by University of Florida. Started Feb 2016; status: completed.

02

Drugs

vorapaxar
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT02545933.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02545933.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call